| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.016 | 0.8 |